@inproceedings{inproceedings, title  = {{Randomized trial of marker-directed versus standard schedule zoledronic acid for bone metastases from breast cancer.}},

 url = {{}},

 year = {{2012}},

 month = {{5}},

 author = {{Coleman RE and Wright J and Houston S and Agrawal R and Purohit OP-K and Hayward L and Simmonds P and Waterhouse A and Marshall H and Investigators BISMARK}},

 volume = {{30}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{15}},

 note = {{Accessed on 2025/10/10}}}